// App-Quantinova.ai

4363 : Loss of PTEN promotes resistance to T cell-mediated immunotherapy

Researchers

Presenter

  • Weiyi Peng

Principal Investigators

  • Chengwen Liu

  • Shruti Malu

  • Caitlin Creasy

  • Michael Tetzlaff

  • Chunyu Xu

  • Jodi McKenzie

  • Chunlei Zhang

  • Xiaoxuan Liang

  • Leila Williams

  • Wanleng Deng

  • Guo Chen

  • Rina Mbofung

  • Alexander Lazar

  • Carlos Torres-Cabala

  • Zachary Cooper

  • Pei-Ling Chen

  • Trang Tieu

  • Stefani Spranger

  • Xiaoxing Yu

  • Chantale Bernatchez

  • Marie-Andree Forget

  • Cara Haymaker

  • Rodabe Amaria

  • Jennifer McQuade

  • Isabella Glitza

  • Tina Cascone

  • Haiyan Li

  • Lawrence Kwong

  • Timothy Heffernan

  • Jianhua Hu

  • Roland Bassett

  • Marcus Bosenberg

  • Scott Woodman

  • Willem Overwijk

  • Gregory Lizee

  • Jason Roszik

  • Thomas Gajewski

  • Jennifer Wargo

  • Jeffrey Gershenwald

  • Laszlo Radvanyi

  • Michael Davies

  • Patrick Hwu

Medical Centers

  • 1.MD Anderson Cancer Center, Houston, TX

  • The University of Chicago Medical Center, Chicago, IL

  • Yale University School of Medicine, New Haven, CT

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Phosphatase and tensin homolog

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved